FNCH
Finch Therapeutics Group, Inc. Common Stock
FNCH
FNCH
Delisted
FNCH was delisted on the 24th of May, 2024.
53 hedge funds and large institutions have $53.1M invested in Finch Therapeutics Group, Inc. Common Stock in 2022 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 8 increasing their positions, 20 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
less capital invested
Capital invested by funds: $ → $
60% less repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 20
Holders
53
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$74.4K | |
| 2 | +$65.9K | |
| 3 | +$46.6K | |
| 4 |
BlackRock
New York
|
+$46.1K |
| 5 |
Renaissance Technologies
New York
|
+$36.8K |
Top Sellers
| 1 | -$3.91M | |
| 2 | -$719K | |
| 3 | -$227K | |
| 4 |
Millennium Management
New York
|
-$126K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$88.3K |